Filter Resources By:
Search Resource Library
Search Results: 25
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Mantle Cell Lymphoma: For Patients
National Comprehensive Cancer Network (NCCN)
NCCN provides comprehensive, evidenced-based clinical practice guidelines for the management of various cancer types, including MCL. The guidelines are updated regularly and offer recommendations for treatment options based on the latest evidence and expert consensus.
Emerging Data Continue to Affect Bruton Tyrosine Kinase (BTK) Inhibitor Usage in Mantle Cell Lymphoma
OncLive
Monica D Mead, MD, is a clinical professor of medicine in hematologic malignancy at the University of California, Los Angeles (UCLA) and discusses the use of various Bruton tyrosine kinase (BTK) inhibitors to treat patients with mantle cell lymphoma in an interview with OncLive®.
Bruton tyrosine kinase (BTK) Inhibitors Stretch Frontline Approaches in Mantle Cell Lymphoma
Targeted Oncology

Recent findings have expanded the use of Bruton tyrosine kinase (BTK) inhibitors for use in combination therapy that has resulted in improved progression-free survival (PFS). Data has emerged stratifying the use of BTK inhibitors in combination with autologous stem cell transplant. These data were presented at major medical conferences in 2022.

Relapsed/Refractory Mantle Cell Lymphoma Trials on Clinicaltrials.gov
National Institutes of Health (NIH)
Clinical trials for relapsed and refractory (R/R) mantle cell lymphoma patients. Many studies are currently enrolling patients.
Treatment for Relapsed/Refractory Mantle Cell Lymphoma Tip Sheet
Association of Cancer Care Centers (ACCC)

Tip sheet to provide a snapshot of the latest information regarding treatment options for patients with MCL, especially with R/R disease.

Understanding Lymphoma: Relapsed/Refractory Mantle Cell Lymphoma Fact Sheet
Lymphoma Research Foundation (LRF)

The document provides an overview of R/R MCL, including its nature, symptoms, treatment options (FDA-approved drugs, stem cell transplants), investigational treatments in clinical trials, and the importance of regular follow-ups and clinical trial participation.

Treating B-Cell Non-Hodgkin Lymphoma
American Cancer Society (ACS)

ACS offers comprehensive information on various cancers, including B-cell non-Hodgkin lymphomas (such as mantle cell lymphoma). Their website provides educational resources for patients and caregivers that review treatment options, side effect management, and support services.

Clinical Trials Support Center (CTSC)
The Leukemia & Lymphoma Society (LLS)

The Clinical Trial Support Center (CTSC) features a nurse clinician who can assist lymphoma patients with identifying clinical trial opportunities for which they may be eligible. LLS is a nonprofit organization focused on funding research and providing support to patients with blood cancers, including lymphomas.

Non-Hodgkin Lymphoma Information Guide
The Leukemia & Lymphoma Society (LLS)

An educational booklet published by LLS that discusses topics relevant to non-Hodgkin lymphomas (such as mantle cell lymphoma). Topics include diagnosis, staging, treatment options, side effect management, financial concerns, and resources for support. LLS is a nonprofit organization focused on funding research and providing support to patients with hematological cancers such as MCL.

LLS Community
The Leukemia & Lymphoma Society (LLS)

The LLS online social network connects people who are living with or supporting someone who has a blood cancer. Members will find the following: thousands of patients and caregivers sharing experiences and information, support from knowledgeable staff, ongoing and accurate disease updates, as well as the opportunity to participate in surveys to improve cancer care.

Health Care Professional Fact Sheet: Facts About Chimeric Antigen Receptor (CAR) T-cell Therapy
The Leukemia & Lymphoma Society (LLS)

The document provides an overview of autologous chimeric antigen receptor (CAR) T-cell therapy for hematologic malignancies, detailing development, clinical applications, efficacy, risks, and the complexities of integrating this personalized treatment into clinical practice.

Cancer Support Community: Education and Resources
Cancer Support Community

A place for patients to share personal stories, inspiration, and updates with other patients and caregivers who are navigating cancer in their own lives or are working to make a positive difference for people who have been impacted by a cancer diagnosis.

Inspire Lymphoma Support Community
Cancer Support Community

The Lymphoma Support Community connects patients and caregivers affected by lymphoma and encourages them to share their personal stories and learn from one another as well as from educational resources provided.

CancerCare: Mantle Cell Lymphoma
CancerCare

CancerCare provides free, professional support services for people affected by mantle cell lymphoma, guided by oncology-specific social workers. Patient education, treatment information, support groups, financial assistance, counseling, and additional resources are available.

Current Treatment Paradigm for Relapsed/Refractory Mantle Cell Lymphoma
OncLive

In this video, William B Pearse, MD, discusses advancements in the treatment of relapsed/refractory mantle cell lymphoma, highlighting the integration of Bruton tyrosine kinase (BTK) inhibitors into frontline therapy, supported by findings from the ongoing phase 3 TRIANGLE study.

Showing Results: 1 - 15 of 25